AbbVie

AbbVie Inc. is a research-based biopharmaceutical company based in North Chicago, Illinois. Established as a spin-off from Abbott Laboratories in 2013, AbbVie focuses on discovering, developing, and delivering advanced therapies for serious diseases in areas such as immunology, oncology, neuroscience, virology, general medicine, eye care, and aesthetics. With around 50,000 employees across more than 70 countries, AbbVie combines pharmaceutical scale with biotech agility to address unmet medical needs. The company has a strong product portfolio, including well-known therapies like Humira for autoimmune diseases, Imbruvica for blood cancers, and Viekira Pak for Hepatitis C. AbbVie has made significant strides in the industry, achieving FDA approvals for various products and expanding its reach through strategic acquisitions, such as Allergan. Its commitment to research and development has allowed it to impact millions of patients worldwide, providing innovative solutions for complex health challenges.